1-6 of 6
data interpretation, statistical
Close
Sort by
Journal Articles

Health-Related Quality-of-Life Outcomes in Patients with Classical Hodgkin Lymphoma: A Prospective, Observational Study in US Oncology Practices

Jakub Svoboda, MD, Philippe Armand, MD PhD, Fiona Taylor, Xiaowu Sun, Alejandro Moreno-Koehler, Srikanth Gajavelli, MD, Derek Peterson, Clara Chen, PhD BS, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2192.
https://doi.org/10.1182/blood-2019-123980
Published: 2019
Journal Articles

Impact of Elotuzumab Plus Pomalidomide and Dexamethasone on Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Enrolled in the ELOQUENT-3 Study

Katja Weisel, Agne Paner, MD, Monika Engelhardt, MD, Fiona Taylor, Kim Cocks, Mihaela Popa-McKiver, PhD, Clara Chen, PhD BS, MS, Michele Cavo
Journal: Blood
Blood (2019) 134 (Supplement_1): 3480.
https://doi.org/10.1182/blood-2019-122232
Published: 2019
Journal Articles

Responses and Cardiotoxicity with R-CDOP and R-CHOP Observed in Frontline Therapy for Patients with Primary Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Randomized Phase-IV Study from Multiple Centers in China

Lili Feng, MD PhD, Xiaoxia Chu, Hongguo Zhao, MD, Yili Wang, Jie Li, Ying Li, MD, Xuehong Ran, Jie Min, Lingyan Zhang, MD, Hongzhi Xu, Jingxia Wang, Ling Wang, Yunliang Hao, Ruirong Xu, Juan Fan, MD, Lei Wang, Xin Wang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2960.
https://doi.org/10.1182/blood-2018-99-116295
Published: 2018
Journal Articles

Quality-of-Life Outcomes in Patients with Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab Plus Pomalidomide and Dexamethasone: Results from the Phase 2 Randomized Eloquent-3 Study

Katja Weisel, MD, Agne Paner, MD, Monika Engelhardt, MD, Fiona Taylor, Kim Cocks, Ashlee Espensen, Mihaela Popa-McKiver, PhD, Clara Chen, PhD BS, MS, Michele Cavo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2288.
https://doi.org/10.1182/blood-2018-99-112080
Published: 2018
Journal Articles

Significance of Bone Marrow Plasma Cell Percentage in Patients with Monoclonal Gammopathy of Unknown Significance Developing Multiple Myeloma

Mona L Vekaria, MD, Bharat Rao, MD, Philip Kuriakose, MD
Journal: Blood
Blood (2014) 124 (21): 5688.
https://doi.org/10.1182/blood.V124.21.5688.5688
Published: 2014
Journal Articles

The Ex-Vivo Expansion of Cytokine Induced Killer (CIK) Cells Can Be Optimized Predicting Cell Expansion Dynamics by Means of Multivariate Statistical Data Analysis

Francesco Rodeghiero, Cristina Zanon, Matteo Stocchero, Elena Albiero, Silvia Castegnaro, Katia Chieregato, Domenico Madeo, Giuseppe Astori
Journal: Blood
Blood (2012) 120 (21): 4125.
https://doi.org/10.1182/blood.V120.21.4125.4125
Published: 2012